Characterization of the urogenital microbiome in Miniature Schnauzers with and without calcium oxalate urolithiasis.


Journal

Journal of veterinary internal medicine
ISSN: 1939-1676
Titre abrégé: J Vet Intern Med
Pays: United States
ID NLM: 8708660

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 24 01 2022
accepted: 15 06 2022
pubmed: 8 7 2022
medline: 27 7 2022
entrez: 7 7 2022
Statut: ppublish

Résumé

Calcium oxalate (CaOx) uroliths are common in dogs. Humans with CaOx urolithiasis exhibit alterations of the urinary and urogenital microbiomes that might mediate urolith formation. Detection of urogenital microbes associated with CaOx in dogs could inform disease pathophysiology. To identify compositional differences in the urogenital microbiome of Miniature Schnauzers with and without CaOx uroliths. Nineteen midstream, voided urine samples from Miniature Schnauzers with (n = 9) and without (n = 10) a history of CaOx urolithiasis. Analytical cross-sectional study. Microbial DNA was extracted from previously frozen urine samples and sequenced for the bacterial 16S rRNA V3-V4 hypervariable regions. Diversity and composition of microbial populations were compared between urolith formers and controls. Alpha and beta diversity measures were similar between groups. Five individual bacterial taxa differed in abundance (indicator values >0.5 and P < .05): Acinetobacter, 2 Geobacillus variants, and Hydrogenophaga were overrepresented in the urine of urolith formers, and Sphingopyxis was overrepresented in controls. Two distinct subtypes of urine microbial composition were observed based on beta diversity measures, independent of urolith status, and other clinical variables. Although we did not detect a difference in the overall urogenital microbial composition between groups, observed differences in individual bacterial taxa might be clinically relevant. For example, Acinetobacter was overrepresented in urolith formers and is associated with CaOx urolithiasis in humans. Two unique clusters of the microbiome were identified, independent of urolith status, which may represent distinct urotypes present in Miniature Schnauzers.

Sections du résumé

BACKGROUND BACKGROUND
Calcium oxalate (CaOx) uroliths are common in dogs. Humans with CaOx urolithiasis exhibit alterations of the urinary and urogenital microbiomes that might mediate urolith formation. Detection of urogenital microbes associated with CaOx in dogs could inform disease pathophysiology.
OBJECTIVE OBJECTIVE
To identify compositional differences in the urogenital microbiome of Miniature Schnauzers with and without CaOx uroliths.
ANIMALS METHODS
Nineteen midstream, voided urine samples from Miniature Schnauzers with (n = 9) and without (n = 10) a history of CaOx urolithiasis.
METHODS METHODS
Analytical cross-sectional study. Microbial DNA was extracted from previously frozen urine samples and sequenced for the bacterial 16S rRNA V3-V4 hypervariable regions. Diversity and composition of microbial populations were compared between urolith formers and controls.
RESULTS RESULTS
Alpha and beta diversity measures were similar between groups. Five individual bacterial taxa differed in abundance (indicator values >0.5 and P < .05): Acinetobacter, 2 Geobacillus variants, and Hydrogenophaga were overrepresented in the urine of urolith formers, and Sphingopyxis was overrepresented in controls. Two distinct subtypes of urine microbial composition were observed based on beta diversity measures, independent of urolith status, and other clinical variables.
CONCLUSIONS AND CLINICAL IMPORTANCE CONCLUSIONS
Although we did not detect a difference in the overall urogenital microbial composition between groups, observed differences in individual bacterial taxa might be clinically relevant. For example, Acinetobacter was overrepresented in urolith formers and is associated with CaOx urolithiasis in humans. Two unique clusters of the microbiome were identified, independent of urolith status, which may represent distinct urotypes present in Miniature Schnauzers.

Identifiants

pubmed: 35796316
doi: 10.1111/jvim.16482
pmc: PMC9308445
doi:

Substances chimiques

RNA, Ribosomal, 16S 0
Calcium Oxalate 2612HC57YE

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1341-1352

Subventions

Organisme : University of Minnesota's College of Veterinary Medicine Resident and Graduate Student Research Grant
Organisme : NIH HHS
ID : T32 OD010993
Pays : United States
Organisme : NIH HHS
ID : K01 OD019912
Pays : United States
Organisme : NIH ORIP K01 Mentored Research Scientist Development Award
ID : K01-OD019912
Organisme : NIH T32 Comparative Medicine and Pathology Training Grant
ID : T32 OD010993-15

Informations de copyright

© 2022 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals LLC on behalf of American College of Veterinary Internal Medicine.

Références

Nucleic Acids Res. 2013 Jan 7;41(1):e1
pubmed: 22933715
PLoS One. 2017 May 17;12(5):e0177783
pubmed: 28545071
Eur J Clin Invest. 2008 Oct;38 Suppl 2:58-65
pubmed: 18826483
Vet Clin North Am Small Anim Pract. 2009 Jan;39(1):183-97
pubmed: 19038658
mSystems. 2017 Sep 26;2(5):
pubmed: 28951890
mBio. 2014 Jul 08;5(4):e01283-14
pubmed: 25006228
New Microbes New Infect. 2016 Jun 06;13:56-8
pubmed: 27408746
Urolithiasis. 2020 Jun;48(3):191-199
pubmed: 31240349
J Vet Intern Med. 2019 Sep;33(5):2090-2095
pubmed: 31471926
Semin Respir Crit Care Med. 2003 Feb;24(1):89-98
pubmed: 16088528
Sci Rep. 2016 Oct 06;6:34712
pubmed: 27708409
BMC Microbiol. 2020 Feb 28;20(1):41
pubmed: 32111156
PLoS One. 2015 Oct 08;10(10):e0139575
pubmed: 26448465
J Vet Intern Med. 2022 Mar;36(2):629-633
pubmed: 35108434
J Vet Intern Med. 2021 Sep;35(5):2263-2270
pubmed: 34322901
J Vet Intern Med. 2015 Jan;29(1):113-9
pubmed: 25581880
Int Urogynecol J. 2019 Nov;30(11):1835-1842
pubmed: 30993388
J Am Vet Med Assoc. 2015 May 15;246(10):1098-103
pubmed: 25932935
J Urol. 2020 Aug;204(2):303-309
pubmed: 32118507
J Vet Intern Med. 2021 May;35(3):1416-1426
pubmed: 33739491
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
BJU Int. 2020 Jan;125(1):133-143
pubmed: 31145528
J Clin Microbiol. 2012 Apr;50(4):1376-83
pubmed: 22278835
PLoS One. 2013 Apr 22;8(4):e61217
pubmed: 23630581
Am J Vet Res. 2002 Mar;63(3):330-7
pubmed: 11911566
J Glob Antimicrob Resist. 2019 Mar;16:59-71
pubmed: 30144636
Rev Infect Dis. 1990 May-Jun;12(3):423-31
pubmed: 2359906
J Vet Intern Med. 2017 Nov;31(6):1740-1748
pubmed: 28941297
J Infect. 1993 Sep;27(2):216-7
pubmed: 8228313
Mamm Genome. 2021 Aug;32(4):232-238
pubmed: 33651197
J Clin Microbiol. 2016 May;54(5):1216-22
pubmed: 26962083
ISME J. 2012 Aug;6(8):1621-4
pubmed: 22402401
mSystems. 2021 Aug 31;6(4):e0051021
pubmed: 34313465
Indian J Med Res. 1997 Jan;105:15-21
pubmed: 9029830
mBio. 2021 Aug 31;12(4):e0200721
pubmed: 34372696
Vet World. 2018 Aug;11(8):1037-1042
pubmed: 30250360
Urolithiasis. 2016 Oct;44(5):399-407
pubmed: 27115405
Microbiome. 2018 Dec 17;6(1):226
pubmed: 30558668
Urolithiasis. 2018 Nov;46(6):503-514
pubmed: 29353409
J Clin Microbiol. 2014 Mar;52(3):871-6
pubmed: 24371246
PLoS One. 2019 Jan 28;14(1):e0211275
pubmed: 30689668
Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6
pubmed: 23193283
Female Pelvic Med Reconstr Surg. 2019 Mar/Apr;25(2):e28-e33
pubmed: 30807432
J Appl Microbiol. 2012 Oct;113(4):745-56
pubmed: 22788835
Sci Rep. 2019 Apr 1;9(1):5425
pubmed: 30932002
Urology. 2003 Aug;62(2):214-7
pubmed: 12893321
J Am Vet Med Assoc. 2010 Jan 15;236(2):193-200
pubmed: 20074011
J Korean Med Sci. 2021 Jan 04;36(1):e3
pubmed: 33398940
Vet Ther. 2004 Fall;5(3):218-31
pubmed: 15578454
Am J Vet Res. 2016 Feb;77(2):162-6
pubmed: 27027710
FEMS Microbiol Rev. 2013 Mar;37(2):130-55
pubmed: 22568581
BMC Urol. 2020 Jan 28;20(1):5
pubmed: 31992287
J Am Vet Med Assoc. 2016 Dec 1;249(11):1274-1280
pubmed: 27875079
PLoS One. 2021 Jul 9;16(7):e0253989
pubmed: 34242284
J Vet Intern Med. 2016 Sep;30(5):1564-1574
pubmed: 27611724
J Am Soc Nephrol. 2008 Jun;19(6):1197-203
pubmed: 18322162
J Vet Diagn Invest. 2002 Mar;14(2):159-62
pubmed: 11939339
J Small Anim Pract. 2022 Apr;63(4):286-292
pubmed: 34897695
Ann Clin Microbiol Antimicrob. 2021 Jan 6;20(1):2
pubmed: 33407528
Microbiome. 2017 Aug 14;5(1):99
pubmed: 28807017
Cell. 2014 Jul 17;158(2):250-262
pubmed: 25036628
ISME J. 2011 Feb;5(2):169-72
pubmed: 20827291
Nature. 2011 May 12;473(7346):174-80
pubmed: 21508958
Sci Rep. 2019 Oct 25;9(1):15291
pubmed: 31653926
Front Microbiol. 2019 Oct 23;10:2407
pubmed: 31708888
J Vet Intern Med. 2022 Jul;36(4):1341-1352
pubmed: 35796316
mSphere. 2019 Jul 31;4(4):
pubmed: 31366708
mSystems. 2021 Aug 31;6(4):e0137120
pubmed: 34282932
BJOG. 2020 Jan;127(2):193-201
pubmed: 31469215
Nat Biotechnol. 2019 Aug;37(8):852-857
pubmed: 31341288
Eur J Clin Microbiol Infect Dis. 1993 Jul;12(7):540-5
pubmed: 8404915

Auteurs

Emily L Coffey (EL)

Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, Saint Paul, Minnesota, USA.

Andres M Gomez (AM)

Department of Animal Science, College of Food, Agricultural and Natural Resource Sciences, University of Minnesota, Saint Paul, Minnesota, USA.

Erin N Burton (EN)

Department of Veterinary and Biomedical Sciences, College of Veterinary Medicine, University of Minnesota, Saint Paul, Minnesota, USA.

Jennifer L Granick (JL)

Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, Saint Paul, Minnesota, USA.

Jody P Lulich (JP)

Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, Saint Paul, Minnesota, USA.

Eva Furrow (E)

Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, Saint Paul, Minnesota, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH